loadpatents
name:-0.0041549205780029
name:-0.0019211769104004
name:-0.00052595138549805
REGINA; Anthony Patent Filings

REGINA; Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for REGINA; Anthony.The latest application filed is for "potentiation of anticancer agents".

Company Profile
0.11.14
  • REGINA; Anthony - Montreal CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Potentiation Of Anticancer Agents
App 20180221497 - BELIVEAU; Richard ;   et al.
2018-08-09
Potentiation of anticancer agents
Grant 9,713,646 - Beliveau , et al. July 25, 2
2017-07-25
Delivery Of Antibodies To The Central Nervous System
App 20170080100 - Beliveau; Richard ;   et al.
2017-03-23
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
Grant 9,365,634 - Beliveau , et al. June 14, 2
2016-06-14
Potentiation Of Anticancer Agents
App 20150314010 - Beliveau; Richard ;   et al.
2015-11-05
Compositions And Methods For The Transport Of Therapeutic Agents
App 20150174267 - CASTAIGNE; Jean-Paul ;   et al.
2015-06-25
Aprotinin Polypeptides For Transporting A Compound Across The Blood-brain Barrier
App 20150174266 - Beliveau; Richard ;   et al.
2015-06-25
Potentiation of anticancer agents
Grant 8,969,310 - Beliveau , et al. March 3, 2
2015-03-03
Aprotinin polypeptides for transporting a compound across the blood-brain barrier
Grant 8,828,949 - Beliveau , et al. September 9, 2
2014-09-09
Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
Grant 8,710,013 - Demeule , et al. April 29, 2
2014-04-29
Compositions And Methods For The Transport Of Therapeutic Agents
App 20120277158 - Castaigne; Jean-Paul ;   et al.
2012-11-01
Aprotinin Polypeptides For Transporting A Compound Across The Blood-brain Barrier
App 20110171128 - BELIVEAU; Richard ;   et al.
2011-07-14
Pharmaceutical Compositions Of Paclitaxel, Paclitaxel Analogs Or Paclitaxel Conjugates And Related Methods Of Preparation And Use
App 20110112036 - Demeule; Michel ;   et al.
2011-05-12
Aprotinin polypeptides for transporting a compound across the blood-brain barrier
Grant 7,902,156 - Beliveau , et al. March 8, 2
2011-03-08
Polypeptide-nucleic Acid Conjugates And Uses Thereof
App 20110039785 - Beliveau; Richard ;   et al.
2011-02-17
Aprotinin-like Polypeptides For Delivering Agents Conjugated Thereto To Tissues
App 20100297120 - Beliveau; Richard ;   et al.
2010-11-25
Molecules for transporting a compound across the blood-brain barrier
Grant 7,557,182 - Beliveau , et al. July 7, 2
2009-07-07
Potentiation of anticancer agents
App 20090082277 - Beliveau; Richard ;   et al.
2009-03-26
Delivery of antibodies to the central nervous system
App 20090016959 - Beliveau; Richard ;   et al.
2009-01-15
Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier
App 20080299039 - Beliveau; Richard ;   et al.
2008-12-04
Molecules for transporting a compound across the blood-brain barrier
App 20060189515 - Beliveau; Richard ;   et al.
2006-08-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed